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Abstract
Background:  Elevated  and  extreme  circulating  levels  of 
lipoprotein(a) (Lp(a)) are considered to be an atherosclerotic risk 
factor, although additional studies on the low levels of Lp(a) are 
necessary to provide confirmation. The carotid intima-media thick-
ness (CIMT) is known as a surrogate index of atherosclerosis. The 
aim of the present study was to investigate the correlation between 
the serum Lp(a) and CIMT in asymptomatic subjects with a rela-
tively low Lp(a) level.
Methods: The study included 65 asymptomatic female Japanese 
subjects (mean age: 60 years) with a serum Lp(a) level < 30 mg/dL. 
Clinical data including the serum Lp(a) and CIMT were measured, 
and their correlations were examined.
Results: The median Lp(a) level was 18.6 mg/dL and the mean 
CIMT level was 0.8 mm.  There was a significant and inverse cor-
relation between the CIMT and Lp(a) (r = − 0.24, P ≤ 0.05), in addi-
tion to a significant and positive correlation between the CIMT and 
subject age and systolic blood pressure. A stepwise multiple linear 
regression analysis identified the Lp(a) to be correlated indepen-
dently, significantly and inversely with the CIMT.
Conclusions: The Lp(a) levels were inversely correlated with the 
CIMT in this population, suggesting that subjects with a low Lp(a) 
level  may  have  a  predisposition  to  carotid  atherosclerosis. This 
finding was preliminary and should be investigated further in larger 
studies and in additional settings.
Keywords: Lp(a); Carotid artery; IMT; Atherosclerosis
Introduction
Elevated,  and  particularly  extreme,  circulating  levels  of 
Lp(a) are considered to be a risk factor for cardiovascular 
disease (CVD) [1-3]. The dual structure of Lp(a), consisting 
of a cholesterol-laden low-density lipoprotein (LDL) particle 
and a plasminogen-like glycoprotein apolipoprotein(a), im-
plies that Lp(a) can contribute to both atherosclerosis and 
thrombosis [2, 3]. In fact, Lp(a) has been observed to accu-
mulate in arterial lesions [4].  However, at present, the role 
of Lp(a) in the pathogenesis of atherosclerosis has not been 
completely elucidated, so the identification of various fac-
tors that affect the association of  Lp(a) with atherosclerotic 
manifestations is necessary.
The sonographic measurement of the thickness of the 
carotid artery, the carotid intima-media thickness (CIMT), is 
one of the best accepted surrogate indices reflecting not only 
local, but also generalized atherosclerosis, associated with 
cardio- and cerebro-vascular morbidity and mortality, even 
in asymptomatic individuals [5]. However, the associations 
observed between the Lp(a) and CIMT have been inconsis-
tent, with several studies having reported positive associa-
tions [6-15], while other reported no significant associations 
[16-24]. There was also a report showing that there was an 
association between the Lp(a) and CIMT only in the severe 
state of the disease [25].
The circulating Lp(a) concentrations vary very widely 
among  the  populations,  and  there  is  generally  a  skewed 
distribution, with a high prevalence of the low concentra-
tions [26-28]. In the Japanese population, the distribution of 
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Lp(a) shows skewing toward the lower concentrations, with 
most of the population having concentrations < 30 mg/dL, 
which is considered to be a presumed normal high level of 
Lp(a) [1]. However, no clinical studies have specifically ex-
amined subjects with a low Lp(a) level. We have noted the 
implications of a low Lp(a) level in two studies [16, 29]. 
In those studies, subjects with high CIMT levels were not 
rarely observed among those with low Lp(a) levels in one 
study [16] and the J-curve phenomenon for the incidence of 
CVD (an increase of the incidence in subjects with the low-
est Lp(a) levels) was observed [29]. These findings may be 
partly related to inconsistent results found for the association 
between the Lp(a) and CIMT [15-25]. Therefore, the present 
study was aimed to investigate the correlation between the 
serum Lp(a) and CIMT in asymptomatic subjects, restricted 
to those with a low Lp(a) level.
Methods
A total of 65 female Japanese subjects were consecutively 
recruited from our outpatient clinics. Eligible subjects were 
asymptomatic, non-pregnant and not taking any medications.   
Only subjects with a serum Lp(a) level < 30 mg/dL were in-
cluded. Subjects who were regular drinkers, and those with a 
history of CVD, malignancy, endocrine disorders, or severe 
kidney and liver diseases were excluded. The institutional 
ethics committee approved the study, and each subject gave 
informed consent.
Current smoking habits were self-reported. The body 
mass index (BMI), seated systolic blood pressure (SBP)/dia-
stolic blood pressure (DBP) in the upper arm, and the plasma 
glucose, serum lipids and Lp(a) levels were measured after 
an overnight fast. The glucose and lipids (TC: total choles-
terol, HDL-C: high-density lipoprotein cholesterol and TG: 
triglycerides) were measured enzymatically, and the serum 
Lp(a) was measured by an ELISA system (Sekisui Medical 
Co. Ltd., Tokyo, Japan). The CIMT of the common carotid 
arteries was measured ultrasonographically by a 10 MHz 
linear type B-mode probe (Xario system: Toshiba Co. Ltd., 
Tokyo, Japan). The CIMT, bilaterally measured in segments 
free of plaque (one at the thickest site and another at two 
other points (1 cm upstream and 1 cm downstream from the 
thickest site)), was averaged for 3 measurements.
The data are expressed as the means ± standard devia-
tion or medians plus interquartile range.  The correlations be-
tween the CIMT and the other variables, including the Lp(a), 
were  examined  by  Pearson’s  correlation  test,  and  subse-
quently, a stepwise multiple linear regression analysis (with 
F for the entry set to 2) adjusted for the measured variables 
(age, smoking, BMI, SBP, DBP, TC, HDL-C, TG, glucose). 
In these analyses, the TG and Lp(a) values were calculated 
after a log-transformation because of their skewed distribu-
tions. A P-value ≤ 0.05 was considered to be significant.
Table 1. Clinical Characteristics of Study Subjects
HDL:  high-density  lipoprotein,  Lp(a):  lipoprotein(a).  The  values  are  ex-
pressed as the means ± standard deviation, medians (interquartile range) 
or numbers.
Variables Levels
Age, years 60 ± 10
Current smoking, n (%) 9 (14%)
Body mass index, kg/m2 23.6 ± 3.6
Systolic blood pressure, mmHg 135 ± 19
Diastolic blood pressure, mmHg 78 ± 9
Total cholesterol, mg/dL 261 ± 38
HDL-cholesterol, mg/dL 68 ± 14
Triglycerides, mg/dL 125 (92 - 181)
Plasma glucose, mg/dL 107 ± 22
Lp(a), mg/dL 18.6 (8.9 - 24.7)
CIMT, mm 0.8 ± 0.2
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Results
The clinical characteristics of the study subjects are listed in 
Table 1. The simple correlations between the CIMT and oth-
er variables, including the Lp(a), are listed in Table 2. There 
was a significant and positive correlation between the CIMT 
and subject age or SBP, while a significant and inverse cor-
relation between the CIMT and Lp(a) was observed.
A stepwise multiple linear regression analysis identified 
subject age to be correlated independently, significantly and 
positively with the CIMT, and the Lp(a) to be correlated in-
dependently, significantly and inversely with the CIMT in 
this population.
Discussion
  
The present study showed that the Lp(a) levels were inverse-
ly correlated with the CIMT in asymptomatic female sub-
jects within a Lp(a) < 30 mg/dL. This suggests that subjects 
with a low Lp(a) level may have a predisposition to carotid 
atherosclerosis.  This  study  was  conducted  in  a  relatively 
small population, and the correlation was not very strong. 
However, if the results are confirmed in large studies, the 
present findings may provide new insights into the physi-
ological roles of Lp(a) in atherosclerosis.
Of importance, a recent investigation has reported that 
when Lp(a) is present at not so high levels, it can function 
as a scavenger that absorbs oxidized lipids in the circula-
tion and vessel walls [30]. Accordingly, some minimal level 
of Lp(a) may be necessary to protect against atherosclerotic 
progression, although this concept will need to be verified 
in additional clinical studies.The circulating Lp(a) levels are 
thought to be largely under genetic control (i.e., at the con-
centration of biosynthesis of the apolipoprotein(a), which is 
encoded by the LPA locus) [31]. A few studies have been 
conducted on the significant association among Lp(a) lev-
els, Lp(a)-related gene polymorphisms and atherosclerosis 
[32, 33]. Although the evidence of the association of the 
gene polymorphisms relating to low Lp(a) levels in subjects 
with atherosclerosis remains insufficient, Lp(a) gene poly-
morphisms and/or its linkage equilibrium may be associated 
with carotid atherosclerosis. In addition, there was a report 
that showed a significant interaction of lifestyle factors (i.e., 
daily fish intake) and Lp(a)-related gene polymorphisms in 
decreasing the Lp(a) levels, although one would generally 
not consider lifestyle factors to have a major influence on 
the Lp(a) levels [34]. We did not obtain information about 
the full lifestyle-related factors of the present study subjects, 
but specific lifestyle-related factors may, at least in part, be 
associated with the results of the present study, from the pre-
vious study findings [34]. Future investigations, taking into 
consideration genetic and lifestyle factors, may be needed to 
clarify the biological importance of the results.
Table 2. Correlations Between the CIMT and Other Variables, Including the Lp(a), in This Population
HDL: high-density lipoprotein, Lp(a): lipoprotein(a). r: simple correlation test (Pearson’s test), β: stepwise multiple linear 
regression analysis adjusted for all the listed variables. Significance level: * P ≤ 0.05.
Variables r P-value β P-value
Age, years 0.33  < 0.01* 0.32  < 0.01*
Current smoking, n (%) 0.06  0.66 Not extracted -
Body mass index, kg/m2 0.06 0.65 Not extracted -
Systolic blood pressure, mmHg 0.30  0.02* Not extracted -
Diastolic blood pressure, mmHg 0.17 0.17 Not extracted -
Total cholesterol, mg/dL 0.05  0.67 Not extracted -
HDL-cholesterol, mg/dL − 0.12  0.33 Not extracted -
Triglycerides, mg/dL 0.02  0.88 Not extracted -
Plasma glucose, mg/dL 0.21  0.09 Not extracted -
Lp(a), mg/dL − 0.24  0.05* − 0.23  0.05*
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There are additional limitations to our study. The pres-
ent study was relatively small and cross-sectional. There-
fore,  we  could  not  conclusively  determine  the  presence 
of any cause-and-effect relationship based on the results. 
Furthermore, our study population was asymptomatic and 
restricted to females and Japanese subjects. Future studies 
on symptomatic diseased patients and males or other ethnic 
groups are required.
In summary, this study found that the Lp(a) levels were 
inversely correlated with the CIMT in asymptomatic female 
subjects, with a serum Lp(a) level < 30 mg/dL. This suggests 
that subjects with a low Lp(a) level may have a predisposi-
tion to carotid atherosclerosis. This clinical finding should 
be further investigated in larger studies and additional set-
tings.
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